Transient and sustained effects of dopamine and serotonin signaling in motivation-related behavior
- PMID: 31599012
- DOI: 10.1111/pcn.12942
Transient and sustained effects of dopamine and serotonin signaling in motivation-related behavior
Abstract
Pharmacological studies of antidepressants and atypical antipsychotics have suggested a role of dopamine and serotonin signaling in depression. However, depressive symptoms and treatment effects are difficult to explain based simply on brain-wide decrease or increase in the concentrations of these molecules. Recent animal studies using advanced neuronal manipulation and observation techniques have revealed detailed dopamine and serotonin dynamics that regulate diverse aspects of motivation-related behavior. Dopamine and serotonin transiently modulate moment-to-moment behavior at timescales ranging from sub-second to minutes and also produce persistent effects, such as reward-related learning and stress responses that last longer than several days. Transient and sustained effects often exhibit specific roles depending on the projection sites, where distinct synaptic and cellular mechanisms are required to process the neurotransmitters for each transient and sustained timescale. Therefore, it appears that specific aspects of motivation-related behavior are regulated by distinct synaptic and cellular mechanisms in specific brain regions that underlie the transient and sustained effects of dopamine and serotonin signaling. Recent clinical studies have implied that subjects with depressive symptoms show impaired transient and sustained signaling functions; moreover, they exhibit heterogeneity in depressive symptoms and neuronal dysfunction. Depressive symptoms may be explained by the dysfunction of each transient and sustained signaling mechanism, and distinct patterns of impairment in the relevant mechanisms may explain the heterogeneity of symptoms. Thus, detailed understanding of dopamine and serotonin signaling may provide new insight into depressive symptoms.
Keywords: depression; dopamine; motivation; serotonin.
© 2019 The Authors. Psychiatry and Clinical Neurosciences © 2019 Japanese Society of Psychiatry and Neurology.
Similar articles
-
Forgetting in Reinforcement Learning Links Sustained Dopamine Signals to Motivation.PLoS Comput Biol. 2016 Oct 13;12(10):e1005145. doi: 10.1371/journal.pcbi.1005145. eCollection 2016 Oct. PLoS Comput Biol. 2016. PMID: 27736881 Free PMC article.
-
Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function.Int Rev Neurobiol. 2015;125:257-302. doi: 10.1016/bs.irn.2015.10.004. Epub 2015 Nov 11. Int Rev Neurobiol. 2015. PMID: 26638769 Review.
-
Chronic unpredictable mild stress-induced behavioral changes are coupled with dopaminergic hyperfunction and serotonergic hypofunction in mouse models of depression.Behav Brain Res. 2019 Oct 17;372:112053. doi: 10.1016/j.bbr.2019.112053. Epub 2019 Jul 6. Behav Brain Res. 2019. PMID: 31288060
-
An Interaction between Serotonin Receptor Signaling and Dopamine Enhances Goal-Directed Vigor and Persistence in Mice.J Neurosci. 2018 Feb 28;38(9):2149-2162. doi: 10.1523/JNEUROSCI.2088-17.2018. Epub 2018 Jan 24. J Neurosci. 2018. PMID: 29367407 Free PMC article.
-
Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response.Curr Drug Targets. 2006 Feb;7(2):165-75. doi: 10.2174/138945006775515491. Curr Drug Targets. 2006. PMID: 16475958 Review.
Cited by
-
Alterations in Serotonin Neurotransmission in Hyperdopaminergic Rats Lacking the Dopamine Transporter.Biomedicines. 2023 Oct 24;11(11):2881. doi: 10.3390/biomedicines11112881. Biomedicines. 2023. PMID: 38001881 Free PMC article.
-
The Relationship Between 5-Hydroxytryptamine and Its Metabolite Changes With Post-stroke Depression.Front Psychiatry. 2022 Apr 26;13:871754. doi: 10.3389/fpsyt.2022.871754. eCollection 2022. Front Psychiatry. 2022. PMID: 35558423 Free PMC article. Review.
-
Dopaminergic nuclei in the chick midbrain express serotonin receptor subfamily genes.Front Physiol. 2022 Nov 8;13:1030621. doi: 10.3389/fphys.2022.1030621. eCollection 2022. Front Physiol. 2022. PMID: 36425295 Free PMC article.
-
Medicinal Cannabis and Central Nervous System Disorders.Front Pharmacol. 2022 Apr 21;13:881810. doi: 10.3389/fphar.2022.881810. eCollection 2022. Front Pharmacol. 2022. PMID: 35529444 Free PMC article. Review.
-
Stable in-vivo electrochemical sensing of tonic serotonin levels using PEDOT/CNT-coated glassy carbon flexible microelectrode arrays.Biosens Bioelectron. 2023 Jun 15;230:115242. doi: 10.1016/j.bios.2023.115242. Epub 2023 Mar 21. Biosens Bioelectron. 2023. PMID: 36989659 Free PMC article.
References
-
- Hindmarch I. Expanding the horizons of depression: Beyond the monoamine hypothesis. Hum. Psychopharmacol. 2001; 16: 203-218.
-
- Spielmans GI, Berman MI, Linardatos E, Rosenlicht NZ, Perry A, Tsai AC. Adjunctive atypical antipsychotic treatment for major depressive disorder: A meta-analysis of depression, quality of life, and safety outcomes. PLoS Med. 2013; 10: e1001403.
-
- Smith RC, Davis JM. Comparative effects of d-amphetamine, l-amphetamine, and methylphenidate on mood in man. Psychopharmacology (Berl.) 1977; 53: 1-12.
-
- Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002; 34: 13-25.
-
- Boku S, Nakagawa S, Toda H, Hishimoto A. Neural basis of major depressive disorder: Beyond monoamine hypothesis. Psychiatry Clin. Neurosci. 2018; 72: 3-12.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
